SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharmaceuticals informs about notice of postal ballot

03 Jun 2024 Evaluate
Further to the outcome of meeting of the Board of Directors of Pharmaids Pharmaceuticals dated May 28, 2024, Pharmaids Pharmaceuticals has enclosed copy of the Postal Ballot Notice dated May 28, 2024 (Notice) to seek approval of the shareholders for the following resolutions: To approve Material Related Party Transaction limits with Anugraha Chemicals (The firm); To approve Material Related Party Transaction limits with Adita Bio Sys Private Limited (Adita); To approve Material Related Party Transaction limits with Siri Labvivo Diet Private Limited (Siri); To approve Material Related Party Transaction limits with Spring Labs (The firm / Spring); etc.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

30.92 -0.49 (-1.56%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×